zoledronic acid has been researched along with Cytokine Release Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Asoda, S; Ito, E; Iwasaki, R; Kaneko, Y; Kawana, H; Kobayashi, T; Matsumoto, M; Miyamoto, K; Miyamoto, T; Nakagawa, T; Nakamura, M; Nakamura, S; Okada, H; Sato, Y; Soma, T; Watanabe, H | 1 |
1 other study(ies) available for zoledronic acid and Cytokine Release Syndrome
Article | Year |
---|---|
Tooth extraction in mice administered zoledronate increases inflammatory cytokine levels and promotes osteonecrosis of the jaw.
Topics: Animals; Apoptosis; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Cell Transdifferentiation; Cytokine Release Syndrome; Cytokines; Disease Models, Animal; Female; Inflammation Mediators; Macrophages; Mice, Inbred C57BL; Models, Biological; Osteoclasts; Osteocytes; Osteogenesis; Porphyromonas gingivalis; Risk Factors; Tooth Extraction; Zoledronic Acid | 2021 |